Windham Tinnell
Pediatrics · Mobile, ALNPI 1689442899
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by UCB, Inc. at 26.1% of the total. Reporting peaked in 2024 at $1,682 and has fallen 57.1% since, to $722 in 2025. Among pediatrics clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $24.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$654
- SK Life Science, Inc.$223
- Argenx US, Inc.$175
- Acadia Pharmaceuticals Inc$164
- AstraZeneca$141
- Genentech USA, Inc.$111
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,508100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 27 | $654 |
| SK Life Science, Inc. | 7 | $223 |
| Argenx US, Inc. | 6 | $175 |
| Acadia Pharmaceuticals Inc | 7 | $164 |
| AstraZeneca(2 entities) | 2 | $141 |
| Genentech USA, Inc. | 5 | $111 |
| Neurocrine Biosciences, Inc. | 4 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| AbbVie | 5 | $81 |
| Novartis | 4 | $72 |
| Jazz Pharmaceuticals Inc. | 3 | $66 |
| Eisai Inc. | 3 | $65 |
| Merz Pharmaceuticals, LLC | 2 | $63 |
| Neurelis, Inc. | 3 | $62 |
| Springworks Therapeutics, Inc. | 2 | $56 |
| Grifols USA, LLC | 2 | $51 |
| Azurity Pharmaceuticals, Inc. | 2 | $49 |
| Tanabe Pharma America, Inc. | 2 | $43 |
| Aucta Pharmaceuticals, Inc. | 3 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| Immedica Pharma US, Inc. | 1 | $27 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Amgen | 1 | $22 |
| Acorda Therapeutics, Inc | 1 | $21 |
| EMD Serono, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$118
How this compares
$2,508 in reported general payments places this provider in the 90th percentile of 908 pediatrics providers in Alabama.
Other pediatrics in Mobile
- James WileyMobile$44K
- Hilary SeayMobile$5K
- Catherine HuettemannMobile$3K
- Richard HuettemannMobile$3K
- Katherine SavellsMobile$2K
- Tamera Coyne-BeasleyBirmingham$154K
- Linda HammettBirmingham$123K
- Darby McElderryBirmingham$111K
- Audrey LloydBirmingham$40K
- Suresh BoppanaBirmingham$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.